[HTML][HTML] Parkinson disease-associated cognitive impairment
Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …
Machine learning for dementia prediction: a systematic review and future research directions
Abstract Nowadays, Artificial Intelligence (AI) and machine learning (ML) have successfully
provided automated solutions to numerous real-world problems. Healthcare is one of the …
provided automated solutions to numerous real-world problems. Healthcare is one of the …
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
S Palmqvist, M Rossi, S Hall, C Quadalti… - Nature Medicine, 2023 - nature.com
Abstract α-Synuclein aggregates constitute the pathology of Lewy body (LB) disease. Little is
known about the effects of LB pathology in preclinical (presymptomatic) individuals, either as …
known about the effects of LB pathology in preclinical (presymptomatic) individuals, either as …
Clinical effects of Lewy body pathology in cognitively impaired individuals
C Quadalti, S Palmqvist, S Hall, M Rossi… - Nature Medicine, 2023 - nature.com
There is poor knowledge about the clinical effects of Lewy body (LB) pathology in patients
with cognitive impairment, especially when coexisting with Alzheimer's disease (AD) …
with cognitive impairment, especially when coexisting with Alzheimer's disease (AD) …
Mental health care for older adults: recent advances and new directions in clinical practice and research
CF Reynolds 3rd, DV Jeste, PS Sachdev… - World …, 2022 - Wiley Online Library
The world's population is aging, bringing about an ever‐greater burden of mental disorders
in older adults. Given multimorbidities, the mental health care of these people and their …
in older adults. Given multimorbidities, the mental health care of these people and their …
Cognitive impairment in older adults: epidemiology, diagnosis, and treatment
NP Palmer, BT Ortega, P Joshi - Psychiatric Clinics, 2022 - psych.theclinics.com
With an increasingly aging population, health care providers will treat a higher number of
patients with cognitive impairment. Identifying cognitive impairment and intervening early …
patients with cognitive impairment. Identifying cognitive impairment and intervening early …
Depression in dementia with Lewy bodies: a critical update
KA Jellinger - Journal of Neural Transmission, 2023 - Springer
Depression with an estimated prevalence of 35% is a frequent manifestation of dementia
with Lewy bodies (DLB), having negative effects on cognitive performance and life …
with Lewy bodies (DLB), having negative effects on cognitive performance and life …
Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
M Koszewicz, J Jaroch, A Brzecka, M Ejma… - Pharmacological …, 2021 - Elsevier
More than 50 million people have various forms of cognitive impairment basically caused by
neurodegenerative diseases, such as Alzheimer's, Parkinson's, and cerebrovascular …
neurodegenerative diseases, such as Alzheimer's, Parkinson's, and cerebrovascular …
Cholinesterase inhibitors for treatment of psychotic symptoms in Alzheimer disease and Parkinson disease: a meta-analysis
E d'Angremont, MJH Begemann, T Van Laar… - Jama …, 2023 - jamanetwork.com
Importance Psychotic symptoms greatly increase the burden of disease for people with
neurodegenerative disorders and their caregivers. Cholinesterase inhibitors (ChEIs) may be …
neurodegenerative disorders and their caregivers. Cholinesterase inhibitors (ChEIs) may be …
Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease
Patients who have dementia with Lewy bodies and Alzheimer's disease show early
degeneration of the cholinergic nucleus basalis of Meynert. However, how white matter …
degeneration of the cholinergic nucleus basalis of Meynert. However, how white matter …